HEADER IMMUNE SYSTEM 20-SEP-22 8EKD TITLE CRYO-EM MAP OF SARS-COV-2 OMICRON BA.2 SPIKE IN COMPLEX WITH 2130-1- TITLE 2 0114-112 COMPND MOL_ID: 1; COMPND 2 MOLECULE: FAB LLNL-199 HC; COMPND 3 CHAIN: E; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: FAB LLNL-199 LC; COMPND 7 CHAIN: F; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: SPIKE PROTEIN S2'; COMPND 11 CHAIN: G; COMPND 12 FRAGMENT: RECEPTOR-BINDING DOMAIN (RBD); COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 13 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS; SOURCE 17 ORGANISM_TAXID: 2901879; SOURCE 18 GENE: S, 2; SOURCE 19 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 20 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 21 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS FAB, COV2, BA.2, OMICRON, IMMUNE SYSTEM EXPDTA ELECTRON MICROSCOPY AUTHOR E.BINSHTEIN,J.E.CROWE REVDAT 4 23-OCT-24 8EKD 1 REMARK REVDAT 3 19-JUN-24 8EKD 1 JRNL REVDAT 2 13-MAR-24 8EKD 1 TITLE JRNL REVDAT 1 21-FEB-24 8EKD 0 JRNL AUTH T.A.DESAUTELS,K.T.ARRILDT,A.T.ZEMLA,E.Y.LAU,F.ZHU,D.RICCI, JRNL AUTH 2 S.CRONIN,S.J.ZOST,E.BINSHTEIN,S.M.SCHEAFFER,B.DADONAITE, JRNL AUTH 3 B.K.PETERSEN,T.B.ENGDAHL,E.CHEN,L.S.HANDAL,L.HALL, JRNL AUTH 4 J.W.GOFORTH,D.VASHCHENKO,S.NGUYEN,D.R.WEILHAMMER,J.K.LO, JRNL AUTH 5 B.RUBINFELD,E.A.SAADA,T.WEISENBERGER,T.H.LEE,B.WHITENER, JRNL AUTH 6 J.B.CASE,A.LADD,M.S.SILVA,R.M.HALUSKA,E.A.GRZESIAK, JRNL AUTH 7 C.G.EARNHART,S.HOPKINS,T.W.BATES,L.B.THACKRAY,B.W.SEGELKE, JRNL AUTH 8 A.M.LILLO,S.SUNDARAM,J.D.BLOOM,M.S.DIAMOND,J.E.CROWE JR., JRNL AUTH 9 R.H.CARNAHAN,D.M.FAISSOL JRNL TITL COMPUTATIONALLY RESTORING THE POTENCY OF A CLINICAL ANTIBODY JRNL TITL 2 AGAINST OMICRON. JRNL REF NATURE V. 629 878 2024 JRNL REFN ESSN 1476-4687 JRNL PMID 38720086 JRNL DOI 10.1038/S41586-024-07385-1 REMARK 2 REMARK 2 RESOLUTION. 3.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : TOPAZ, EPU, CTFFIND, UCSF CHIMERA, REMARK 3 RELION, RELION, RELION, RELION, PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : 7L7E REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.600 REMARK 3 NUMBER OF PARTICLES : 386950 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8EKD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-SEP-22. REMARK 100 THE DEPOSITION ID IS D_1000268405. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : SARS COV2 OMICRON BA.2 RBD REMARK 245 COMPLEX WITH FAB LLNL-199; SARS REMARK 245 COV2 OMICRON BA.2 RBD; FAB LLNL- REMARK 245 199 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 0.60 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 23469 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 800.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 1800.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5217.30 REMARK 245 ILLUMINATION MODE : OTHER REMARK 245 NOMINAL MAGNIFICATION : 130000 REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU E 91 REMARK 465 ASP E 92 REMARK 465 THR E 93 REMARK 465 ALA E 94 REMARK 465 SER E 131 REMARK 465 ASP F 1 REMARK 465 ARG F 113 REMARK 465 ILE G 358 REMARK 465 SER G 359 REMARK 465 ASN G 360 REMARK 465 CYS G 361 REMARK 465 VAL G 362 REMARK 465 ASP G 389 REMARK 465 LEU G 390 REMARK 465 CYS G 391 REMARK 465 PHE G 392 REMARK 465 THR G 393 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS E 78 CG CD CE NZ REMARK 470 VAL G 382 CG1 CG2 REMARK 470 SER G 383 OG REMARK 470 THR G 385 OG1 CG2 REMARK 470 SER G 469 OG REMARK 470 THR G 500 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PRO F 8 OG1 THR F 107 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO G 507 CA - N - CD ANGL. DEV. = -8.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP F 56 15.30 58.18 REMARK 500 ALA F 57 -3.59 68.10 REMARK 500 SER F 58 -37.85 -132.34 REMARK 500 PRO F 65 -173.77 -69.58 REMARK 500 SER F 71 117.40 -160.55 REMARK 500 THR F 100 -159.80 53.78 REMARK 500 ASP G 428 58.90 -98.66 REMARK 500 LEU G 441 -60.57 -90.23 REMARK 500 THR G 470 35.86 -85.98 REMARK 500 ALA G 475 -129.21 56.30 REMARK 500 CYS G 480 -11.14 72.78 REMARK 500 ASN G 487 -1.30 66.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-28199 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF SARS COV2 OMICRON BA.2 RBD IN COMPLEX WITH REMARK 900 LLNL-199 DBREF 8EKD E 1 131 PDB 8EKD 8EKD 1 131 DBREF 8EKD F 1 113 PDB 8EKD 8EKD 1 113 DBREF 8EKD G 333 516 UNP P0DTC2 SPIKE_SARS2 333 516 SEQADV 8EKD ASP G 339 UNP P0DTC2 GLY 339 CONFLICT SEQADV 8EKD PHE G 371 UNP P0DTC2 SER 371 CONFLICT SEQADV 8EKD PRO G 373 UNP P0DTC2 SER 373 CONFLICT SEQADV 8EKD PHE G 375 UNP P0DTC2 SER 375 CONFLICT SEQADV 8EKD ALA G 376 UNP P0DTC2 THR 376 CONFLICT SEQADV 8EKD ASN G 405 UNP P0DTC2 ASP 405 CONFLICT SEQADV 8EKD SER G 408 UNP P0DTC2 ARG 408 CONFLICT SEQADV 8EKD ASN G 417 UNP P0DTC2 LYS 417 CONFLICT SEQADV 8EKD LYS G 440 UNP P0DTC2 ASN 440 CONFLICT SEQADV 8EKD ASN G 477 UNP P0DTC2 SER 477 CONFLICT SEQADV 8EKD LYS G 478 UNP P0DTC2 THR 478 CONFLICT SEQADV 8EKD ALA G 484 UNP P0DTC2 GLU 484 CONFLICT SEQADV 8EKD ARG G 493 UNP P0DTC2 GLN 493 CONFLICT SEQADV 8EKD ARG G 498 UNP P0DTC2 GLN 498 CONFLICT SEQADV 8EKD TYR G 501 UNP P0DTC2 ASN 501 CONFLICT SEQADV 8EKD HIS G 505 UNP P0DTC2 TYR 505 CONFLICT SEQRES 1 E 131 GLU VAL GLN LEU VAL GLU SER GLY GLY GLY LEU VAL LYS SEQRES 2 E 131 PRO GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 E 131 PHE THR PHE ARG ASP VAL TRP MET SER TRP VAL ARG GLN SEQRES 4 E 131 ALA PRO GLY LYS GLY LEU GLU TRP VAL GLY ARG ILE LYS SEQRES 5 E 131 SER LYS ILE ASP GLY GLY THR THR ASP TYR ALA ALA PRO SEQRES 6 E 131 VAL LYS GLY ARG PHE THR ILE SER ARG ASP ASP SER LYS SEQRES 7 E 131 ASN THR LEU TYR LEU GLN MET ASN SER LEU LYS THR GLU SEQRES 8 E 131 ASP THR ALA VAL TYR TYR CYS THR THR ALA GLY SER TYR SEQRES 9 E 131 TYR TYR ASP THR VAL GLY PRO GLU LEU PRO GLU GLY LYS SEQRES 10 E 131 PHE ASP TYR TRP GLY GLN GLY THR LEU VAL THR VAL SER SEQRES 11 E 131 SER SEQRES 1 F 113 ASP ILE VAL MET THR GLN SER PRO ASP SER LEU ALA VAL SEQRES 2 F 113 SER LEU GLY GLU ARG ALA THR ILE ASN CYS LYS SER SER SEQRES 3 F 113 GLN SER VAL LEU TYR ALA ALA ASN ASN LYS ASN TYR LEU SEQRES 4 F 113 ALA TRP TYR GLN GLN LYS PRO GLY GLN PRO PRO LYS LEU SEQRES 5 F 113 LEU MET TYR TRP ALA SER GLU ARG GLU SER GLY VAL PRO SEQRES 6 F 113 ASP ARG PHE SER GLY SER GLY SER GLY ALA GLU PHE THR SEQRES 7 F 113 LEU THR ILE SER SER LEU GLN ALA GLU ASP VAL ALA ILE SEQRES 8 F 113 TYR TYR CYS GLN GLN TYR TYR SER THR LEU THR PHE GLY SEQRES 9 F 113 GLY GLY THR LYS VAL GLU ILE LYS ARG SEQRES 1 G 184 THR ASN LEU CYS PRO PHE ASP GLU VAL PHE ASN ALA THR SEQRES 2 G 184 ARG PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG ILE SEQRES 3 G 184 SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN PHE SEQRES 4 G 184 ALA PRO PHE PHE ALA PHE LYS CYS TYR GLY VAL SER PRO SEQRES 5 G 184 THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR ALA SEQRES 6 G 184 ASP SER PHE VAL ILE ARG GLY ASN GLU VAL SER GLN ILE SEQRES 7 G 184 ALA PRO GLY GLN THR GLY ASN ILE ALA ASP TYR ASN TYR SEQRES 8 G 184 LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA TRP SEQRES 9 G 184 ASN SER ASN LYS LEU ASP SER LYS VAL GLY GLY ASN TYR SEQRES 10 G 184 ASN TYR LEU TYR ARG LEU PHE ARG LYS SER ASN LEU LYS SEQRES 11 G 184 PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN ALA SEQRES 12 G 184 GLY ASN LYS PRO CYS ASN GLY VAL ALA GLY PHE ASN CYS SEQRES 13 G 184 TYR PHE PRO LEU ARG SER TYR GLY PHE ARG PRO THR TYR SEQRES 14 G 184 GLY VAL GLY HIS GLN PRO TYR ARG VAL VAL VAL LEU SER SEQRES 15 G 184 PHE GLU HET NAG G 601 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 4 NAG C8 H15 N O6 HELIX 1 AA1 ALA E 64 LYS E 67 5 4 HELIX 2 AA2 PRO G 337 ASN G 343 1 7 HELIX 3 AA3 TYR G 365 PHE G 371 1 7 HELIX 4 AA4 ASN G 405 VAL G 407 5 3 HELIX 5 AA5 GLY G 416 TYR G 421 1 6 SHEET 1 AA1 4 GLN E 3 SER E 7 0 SHEET 2 AA1 4 SER E 17 SER E 25 -1 O ALA E 23 N VAL E 5 SHEET 3 AA1 4 THR E 80 ASN E 86 -1 O MET E 85 N LEU E 18 SHEET 4 AA1 4 PHE E 70 ARG E 74 -1 N THR E 71 O GLN E 84 SHEET 1 AA2 2 LEU E 11 VAL E 12 0 SHEET 2 AA2 2 THR E 128 VAL E 129 1 O THR E 128 N VAL E 12 SHEET 1 AA3 4 THR E 60 TYR E 62 0 SHEET 2 AA3 4 LEU E 45 ILE E 51 -1 N ARG E 50 O ASP E 61 SHEET 3 AA3 4 SER E 35 GLN E 39 -1 N ARG E 38 O GLU E 46 SHEET 4 AA3 4 TYR E 96 THR E 99 -1 O TYR E 97 N VAL E 37 SHEET 1 AA4 4 MET F 4 SER F 7 0 SHEET 2 AA4 4 ALA F 19 SER F 25 -1 O LYS F 24 N THR F 5 SHEET 3 AA4 4 GLU F 76 ILE F 81 -1 O PHE F 77 N CYS F 23 SHEET 4 AA4 4 PHE F 68 SER F 73 -1 N SER F 69 O THR F 80 SHEET 1 AA5 6 SER F 10 ALA F 12 0 SHEET 2 AA5 6 THR F 107 GLU F 110 1 O LYS F 108 N LEU F 11 SHEET 3 AA5 6 ILE F 91 GLN F 96 -1 N TYR F 92 O THR F 107 SHEET 4 AA5 6 LEU F 39 GLN F 44 -1 N GLN F 44 O ILE F 91 SHEET 5 AA5 6 PRO F 50 TYR F 55 -1 O LEU F 53 N TRP F 41 SHEET 6 AA5 6 GLU F 59 ARG F 60 -1 O GLU F 59 N TYR F 55 SHEET 1 AA6 4 ASN G 354 LYS G 356 0 SHEET 2 AA6 4 VAL G 395 ARG G 403 -1 O ALA G 397 N LYS G 356 SHEET 3 AA6 4 PRO G 507 PHE G 515 -1 O TYR G 508 N ILE G 402 SHEET 4 AA6 4 GLY G 431 CYS G 432 -1 N CYS G 432 O LEU G 513 SHEET 1 AA7 2 LEU G 452 ARG G 454 0 SHEET 2 AA7 2 LEU G 492 SER G 494 -1 O ARG G 493 N TYR G 453 SSBOND 1 CYS E 22 CYS E 98 1555 1555 2.03 SSBOND 2 CYS F 23 CYS F 94 1555 1555 2.03 SSBOND 3 CYS G 379 CYS G 432 1555 1555 2.03 LINK ND2 ASN G 343 C1 NAG G 601 1555 1555 1.44 CISPEP 1 SER F 7 PRO F 8 0 -4.24 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000